What does an Epstein‑Barr virus viral capsid antigen IgG level of 430 U/mL and EBV nuclear antigen IgG level of 75 U/mL indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EBV Serology Interpretation: Past Infection

Your results indicate a past EBV infection that occurred more than 6 weeks ago, not a recent or active infection. Both VCA IgG and EBNA IgG are positive, which is the classic serological pattern of remote EBV exposure 1.

Understanding Your Results

What These Antibodies Mean

  • VCA IgG (430 U/mL - Positive): This antibody develops during acute EBV infection and persists for life. Over 90% of normal adults have detectable VCA IgG 1.

  • EBNA IgG (75.3 U/mL - Positive): This is the key marker for timing. EBNA antibodies develop 1-2 months or more after primary infection and remain detectable for life 1. The presence of EBNA antibodies indicates infection occurred more than 6 weeks ago and therefore EBV is not likely the cause of any current symptoms 1.

What's Missing (and Why It Matters)

The critical piece of information is whether VCA IgM was tested. According to IDSA/ASM guidelines:

  • VCA IgM present + EBNA absent = Recent primary infection
  • VCA IgG present + EBNA present + VCA IgM absent = Past infection (your likely scenario) 1

Clinical Significance

This Pattern Means:

  • You were infected with EBV at some point in the past (likely months to years ago)
  • You are not currently experiencing acute mononucleosis
  • This is a normal finding in the general adult population
  • These antibodies will remain positive for life

Important Caveats:

Approximately 5-10% of people who have been infected with EBV fail to develop EBNA antibodies 1. However, since yours is clearly positive, this exception doesn't apply to you.

When to Consider Further Evaluation:

If you have persistent symptoms (fever, lymphadenopathy, fatigue lasting >3 months), extremely elevated VCA IgG titers (typically >1:640 by older methods), or are immunocompromised, consider:

  • VCA IgM testing if not already done
  • EBV viral load (DNA quantification) in whole blood - particularly if immunocompromised or symptoms suggest chronic active EBV infection 1
  • Evaluation for other causes of your symptoms (CMV, HIV, toxoplasmosis, autoimmune conditions)

Chronic active EBV infection is rare and requires persistent symptoms plus either unusually elevated antibody patterns (VCA-IgG ≥1:640 and EA-IgG ≥1:160) or elevated EBV DNA load (>10^2.5 copies/mg DNA in peripheral blood mononuclear cells) 2. Your current results alone do not suggest this diagnosis.

Bottom Line:

Your serology shows normal, expected antibodies from a past EBV infection. If you're currently symptomatic, EBV is not the likely culprit, and alternative diagnoses should be pursued.

Related Questions

What is the clinical significance of an Epstein-Barr virus viral capsid antigen IgG result reported as less than 36 U/mL?
What does a VCA (viral capsid antigen) EBV (Epstein‑Barr virus) IgG level greater than 750 U indicate?
What does a persistently elevated Epstein-Barr virus (EBV) viral capsid antigen (VCA) IgG with a negative VCA IgM over the past year indicate?
What does a rising Epstein‑Barr virus IgG level with IgM below the laboratory cutoff (<10 U/mL) indicate about infection status and recommended management?
What are the various Epstein‑Barr virus antibodies (viral capsid antigen IgM, viral capsid antigen IgG, Epstein‑Barr nuclear antigen IgG, early antigen IgG) and when do they typically develop during infection?
What is the likely diagnosis for a patient with mid‑epigastric abdominal pain and nausea after a fatty meal that radiates to the back?
In a healthy 29-year-old who has been treated three times for upper respiratory tract infection symptoms with cough and cold medication (CTM), guaifenesin, and acetaminophen (Tylenol), what is the next step in management?
After unilateral nephrectomy, can the remaining kidney handle the same fluid load as both kidneys did?
What is the recommended management for decompensated chronic liver disease?
What alternative supportive therapies can be offered for a patient with acute sinusitis or cough when antibiotic criteria are not met, instead of the usual cough‑and‑cold combination, guaifenesin, and acetaminophen?
In an intubated patient, what is the interpretation and recommended management of an arterial blood gas (ABG) showing pH 7.46, PaCO2 (partial pressure of carbon dioxide) 29 mm Hg, PaO2 (partial pressure of oxygen) 68.7 mm Hg on FiO2 (fraction of inspired oxygen) 0.85, and HCO3‑ (bicarbonate) 20.3 mmol/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.